LABESFAL is part of the Fresenius Kabi AG Group, subsidiary of the Fresenius SE Group and has one of the most modern pharmaceutical production infrastructures. On a commercial level, LABESFAL's activity is focused on 4 essential spheres of influence: Hospital Market, Generic Drugs Market, International Market and Third Parties Production.